Since NK cells lack T cell receptors (TCRs), they do not recognize tumor cells via the major histocompatibility complex class I (MHC-I) molecule, and can instead target malignant cells that have shed MHC (31, 32). The gene discussed is HLA-C; the disease is neoplasm.